DK1654352T3 - Reversibelt immortaliserede olfaktoriske indhyllende glia og deres anvendelse til fremme af neuronregenerering - Google Patents
Reversibelt immortaliserede olfaktoriske indhyllende glia og deres anvendelse til fremme af neuronregenereringInfo
- Publication number
- DK1654352T3 DK1654352T3 DK04743484T DK04743484T DK1654352T3 DK 1654352 T3 DK1654352 T3 DK 1654352T3 DK 04743484 T DK04743484 T DK 04743484T DK 04743484 T DK04743484 T DK 04743484T DK 1654352 T3 DK1654352 T3 DK 1654352T3
- Authority
- DK
- Denmark
- Prior art keywords
- capacity
- cell lines
- cns
- glia
- oegs
- Prior art date
Links
- 210000004498 neuroglial cell Anatomy 0.000 title abstract 2
- 230000009689 neuronal regeneration Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 5
- 210000003169 central nervous system Anatomy 0.000 abstract 4
- 230000003376 axonal effect Effects 0.000 abstract 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- 208000003098 Ganglion Cysts Diseases 0.000 abstract 1
- 206010061431 Glial scar Diseases 0.000 abstract 1
- 206010018341 Gliosis Diseases 0.000 abstract 1
- 208000005400 Synovial Cyst Diseases 0.000 abstract 1
- 210000003050 axon Anatomy 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 230000003961 neuronal insult Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/30—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cancer cells, e.g. reversion of tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Acoustics & Sound (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0316882.0A GB0316882D0 (en) | 2003-07-18 | 2003-07-18 | Reversible immortalization of OEG from human olfactory bulbs as a tool to promote spinal cord regeneration |
| PCT/GB2004/003149 WO2005012513A1 (en) | 2003-07-18 | 2004-07-19 | Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1654352T3 true DK1654352T3 (da) | 2008-07-07 |
Family
ID=27764099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04743484T DK1654352T3 (da) | 2003-07-18 | 2004-07-19 | Reversibelt immortaliserede olfaktoriske indhyllende glia og deres anvendelse til fremme af neuronregenerering |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070134213A1 (de) |
| EP (1) | EP1654352B1 (de) |
| JP (1) | JP2007536901A (de) |
| KR (1) | KR100985191B1 (de) |
| CN (1) | CN100554410C (de) |
| AT (1) | ATE384131T1 (de) |
| AU (1) | AU2004261763B8 (de) |
| CA (1) | CA2531320A1 (de) |
| DE (1) | DE602004011361T2 (de) |
| DK (1) | DK1654352T3 (de) |
| ES (1) | ES2299842T3 (de) |
| GB (1) | GB0316882D0 (de) |
| HR (1) | HRP20080051T3 (de) |
| IL (1) | IL172831A (de) |
| PL (1) | PL1654352T3 (de) |
| PT (1) | PT1654352E (de) |
| WO (1) | WO2005012513A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL212052B1 (pl) * | 2005-12-14 | 2012-08-31 | Akademia Medyczna Im Piastow Śląskich We Wrocławiu | Sposób pozyskiwania glejowych komórek węchowych i ich zastosowania |
| DK3257943T3 (da) * | 2010-11-02 | 2019-10-21 | Helmholtz Zentrum Infektionsforschung Gmbh | Fremgangsmåder og vektorer til celleimmortalisering |
| WO2012164137A1 (es) | 2011-05-30 | 2012-12-06 | Fundación Investigación En Regeneración Del Sistema Nervioso | Células madre y células de la estirpe neural derivadas de la glía envolvente olfatoria, y sus aplicaciones |
| CN108430582B (zh) * | 2015-12-04 | 2020-02-21 | 宾州研究基金会 | 用小分子混合物将人神经胶质细胞化学重编程为神经元 |
| CN108277201A (zh) * | 2016-12-30 | 2018-07-13 | 中国医药大学 | 成体多功能嗅干细胞及其分离方法以及其应用 |
| CN113355354A (zh) * | 2020-03-03 | 2021-09-07 | 杭州启函生物科技有限公司 | 控制细胞行为的系统和方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629159A (en) * | 1995-06-07 | 1997-05-13 | California Institute Of Technology | Immortalization and disimmortalization of cells |
| AUPQ369599A0 (en) * | 1999-10-27 | 1999-11-18 | Griffith University | A method of preparing olfactory cells for transplantation |
| AUPQ614200A0 (en) * | 2000-03-10 | 2000-03-30 | Department Of Human Physiology, Flinders University School Of Medicine | Method for treating chronic spinal cord injury |
| US7033744B2 (en) * | 2001-03-16 | 2006-04-25 | Naoya Kobayashi | Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof |
| US7521234B2 (en) * | 2001-03-16 | 2009-04-21 | Naoya Kobayashi | Mammalian immortalized liver cell |
| ES2190336B1 (es) * | 2001-04-19 | 2005-02-01 | Consejo Superior De Investigaciones Cientificas | Glia envolvente olfatoria modificada geneticamente mediante introduccion de telomerasa. |
| US6645763B2 (en) * | 2001-10-12 | 2003-11-11 | Naoya Kobayashi | Immortalized bone marrow mesenchymal stem cell |
-
2003
- 2003-07-18 GB GBGB0316882.0A patent/GB0316882D0/en not_active Ceased
-
2004
- 2004-07-19 WO PCT/GB2004/003149 patent/WO2005012513A1/en not_active Ceased
- 2004-07-19 AT AT04743484T patent/ATE384131T1/de not_active IP Right Cessation
- 2004-07-19 CA CA002531320A patent/CA2531320A1/en not_active Abandoned
- 2004-07-19 KR KR1020067001231A patent/KR100985191B1/ko not_active Expired - Fee Related
- 2004-07-19 DE DE602004011361T patent/DE602004011361T2/de not_active Expired - Lifetime
- 2004-07-19 CN CNB2004800206634A patent/CN100554410C/zh not_active Expired - Fee Related
- 2004-07-19 PT PT04743484T patent/PT1654352E/pt unknown
- 2004-07-19 ES ES04743484T patent/ES2299842T3/es not_active Expired - Lifetime
- 2004-07-19 PL PL04743484T patent/PL1654352T3/pl unknown
- 2004-07-19 EP EP04743484A patent/EP1654352B1/de not_active Expired - Lifetime
- 2004-07-19 DK DK04743484T patent/DK1654352T3/da active
- 2004-07-19 HR HR20080051T patent/HRP20080051T3/xx unknown
- 2004-07-19 US US10/564,466 patent/US20070134213A1/en not_active Abandoned
- 2004-07-19 AU AU2004261763A patent/AU2004261763B8/en not_active Ceased
- 2004-07-19 JP JP2006520020A patent/JP2007536901A/ja active Pending
-
2005
- 2005-12-26 IL IL172831A patent/IL172831A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL172831A0 (en) | 2006-06-11 |
| CN1823161A (zh) | 2006-08-23 |
| JP2007536901A (ja) | 2007-12-20 |
| PL1654352T3 (pl) | 2008-06-30 |
| PT1654352E (pt) | 2008-04-21 |
| ATE384131T1 (de) | 2008-02-15 |
| AU2004261763B2 (en) | 2010-01-28 |
| KR100985191B1 (ko) | 2010-10-05 |
| CA2531320A1 (en) | 2005-02-10 |
| DE602004011361T2 (de) | 2008-10-23 |
| AU2004261763B8 (en) | 2011-01-06 |
| GB0316882D0 (en) | 2003-08-20 |
| HRP20080051T3 (hr) | 2008-07-31 |
| DE602004011361D1 (de) | 2008-03-06 |
| CN100554410C (zh) | 2009-10-28 |
| AU2004261763A1 (en) | 2005-02-10 |
| WO2005012513A1 (en) | 2005-02-10 |
| ES2299842T3 (es) | 2008-06-01 |
| US20070134213A1 (en) | 2007-06-14 |
| IL172831A (en) | 2011-05-31 |
| KR20060091293A (ko) | 2006-08-18 |
| EP1654352A1 (de) | 2006-05-10 |
| EP1654352B1 (de) | 2008-01-16 |
| WO2005012513A8 (en) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hernández et al. | Differentiation of human mesenchymal stem cells towards neuronal lineage: clinical trials in nervous system disorders | |
| Harrell et al. | Therapeutic potential of mesenchymal stem cells and their secretome in the treatment of glaucoma | |
| Wang et al. | Advances of tooth‐derived stem cells in neural diseases treatments and nerve tissue regeneration | |
| Lampe et al. | Effect of macromer weight percent on neural cell growth in 2D and 3D nondegradable PEG hydrogel culture | |
| Raivich et al. | The making of successful axonal regeneration: genes, molecules and signal transduction pathways | |
| ATE420188T1 (de) | Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren | |
| Liu et al. | Placental trophoblasts shifted Th1/Th2 balance toward Th2 and inhibited Th17 immunity at fetomaternal interface | |
| Murugan Girija et al. | Transdifferentiation of human gingival mesenchymal stem cells into functional keratinocytes by Acalypha indica in three‐dimensional microenvironment | |
| DK1654352T3 (da) | Reversibelt immortaliserede olfaktoriske indhyllende glia og deres anvendelse til fremme af neuronregenerering | |
| Lim et al. | Concentration dependent survival and neural differentiation of murine embryonic stem cells cultured on polyethylene glycol dimethacrylate hydrogels possessing a continuous concentration gradient of n-cadherin derived peptide His-Ala-Val-Asp-Lle | |
| Zeidler et al. | NOCICEPTRA: gene and microRNA signatures and their trajectories characterizing human iPSC‐derived nociceptor maturation | |
| Huang et al. | Hypoxic preconditioning ameliorated neuronal injury after middle cerebral artery occlusion by promoting neurogenesis | |
| German et al. | Retina stem cells, hopes and obstacles | |
| Qian et al. | Brain repair by cell replacement via in situ neuronal reprogramming | |
| ATE420101T1 (de) | Isolierung von nervenstammzellen unter verwendung von gangliosiden und anderen oberflächenmarkern | |
| Beristain et al. | Organoids in modeling human trophoblast development | |
| WO2009155301A3 (en) | Multipotent neural cells | |
| ATE411352T1 (de) | Ionenleitende polymere und diese enthaltende membranen | |
| Gao et al. | Direct induction of neural progenitor cells transiently passes through a partially reprogrammed state | |
| WO2005118920A3 (en) | Methods for generating neuronal cells from human embryonic stem cells and uses thereof | |
| Fazeli et al. | Expression pattern of neuronal markers in PB-MSCs treated by growth factors noggin, bFGF and EGF | |
| Chung et al. | Monocyte inflammatory and matrix remodeling response modulated by grafted ECM‐derived ligand concentration | |
| Rivolta | Stem cells and cell lines from the human auditory organ: applications, hurdles and bottlenecks in the development of regenerative therapies for deafness | |
| Wang et al. | Effects on Proliferation and Differentiation of Human Umbilical Cord‐Derived Mesenchymal Stem Cells Engineered to Express Neurotrophic Factors | |
| Tsonis et al. | To regeneration... with complement |